191 related articles for article (PubMed ID: 16774687)
1. C-reactive protein in degenerative aortic valve stenosis.
Sanchez PL; Mazzone A
Cardiovasc Ultrasound; 2006 Jun; 4():24. PubMed ID: 16774687
[TBL] [Abstract][Full Text] [Related]
2. C-reactive protein in aortic valve disease.
Sanchez PL; Mazzone AM
Cardiovasc Ultrasound; 2006 Oct; 4():37. PubMed ID: 17042945
[TBL] [Abstract][Full Text] [Related]
3. Aortic valve stenosis and coronary artery disease: pathophysiological and clinical links.
Mazzone A; Venneri L; Berti S
J Cardiovasc Med (Hagerstown); 2007 Dec; 8(12):983-9. PubMed ID: 18163008
[TBL] [Abstract][Full Text] [Related]
4. A comparative study of immunodepletion and equalization methods for aortic stenosis human plasma.
Gil-Dones F; Darde VM; Vivanco F; Barderas MG
Methods Mol Biol; 2013; 1005():245-56. PubMed ID: 23606263
[TBL] [Abstract][Full Text] [Related]
5. Clinical factors, but not C-reactive protein, predict progression of calcific aortic-valve disease: the Cardiovascular Health Study.
Novaro GM; Katz R; Aviles RJ; Gottdiener JS; Cushman M; Psaty BM; Otto CM; Griffin BP
J Am Coll Cardiol; 2007 Nov; 50(20):1992-8. PubMed ID: 17996566
[TBL] [Abstract][Full Text] [Related]
6. Tissue resident C reactive protein in degenerative aortic valves: correlation with serum C reactive protein concentrations and modification by statins.
Skowasch D; Schrempf S; Preusse CJ; Likungu JA; Welz A; Lüderitz B; Bauriedel G
Heart; 2006 Apr; 92(4):495-8. PubMed ID: 16159975
[TBL] [Abstract][Full Text] [Related]
7. Effect of statin treatment on aortic valve and coronary artery calcification.
Mohler ER; Wang H; Medenilla E; Scott C
J Heart Valve Dis; 2007 Jul; 16(4):378-86. PubMed ID: 17702362
[TBL] [Abstract][Full Text] [Related]
8. [Calcific and degenerative aortic stenosis--pathogenesis and new possibilities of treatment].
Podolec P; Kopeć G; Rubiś P; Kabłak-Ziembicka A; Rokita E; Tracz W
Przegl Lek; 2004; 61(6):604-8. PubMed ID: 15724645
[TBL] [Abstract][Full Text] [Related]
9. Neoangiogenesis, T-lymphocyte infiltration, and heat shock protein-60 are biological hallmarks of an immunomediated inflammatory process in end-stage calcified aortic valve stenosis.
Mazzone A; Epistolato MC; De Caterina R; Storti S; Vittorini S; Sbrana S; Gianetti J; Bevilacqua S; Glauber M; Biagini A; Tanganelli P
J Am Coll Cardiol; 2004 May; 43(9):1670-6. PubMed ID: 15120829
[TBL] [Abstract][Full Text] [Related]
10. C-reactive protein to identify early risk for development of calcific aortic stenosis: right marker? Wrong time?
Stone PH
J Am Coll Cardiol; 2007 Nov; 50(20):1999-2001. PubMed ID: 17996567
[No Abstract] [Full Text] [Related]
11. Valvular aortic stenosis: disease severity and timing of intervention.
Otto CM
J Am Coll Cardiol; 2006 Jun; 47(11):2141-51. PubMed ID: 16750677
[TBL] [Abstract][Full Text] [Related]
12. [Aortic stenosis].
Rosenhek R
Rev Prat; 2009 Feb; 59(2):178-81. PubMed ID: 19317129
[TBL] [Abstract][Full Text] [Related]
13. Biological features (inflammation and neoangiogenesis) and atherosclerotic risk factors in carotid plaques and calcified aortic valve stenosis: two different sites of the same disease?
Mazzone A; Epistolato MC; Gianetti J; Castagnini M; Sassi C; Ceravolo R; Bevilacqua S; Glauber M; Biagini A; Tanganelli P
Am J Clin Pathol; 2006 Oct; 126(4):494-502. PubMed ID: 16938654
[TBL] [Abstract][Full Text] [Related]
14. Calcific aortic valve disease and aortic atherosclerosis--two faces of the same disease?
Ginghină C; Florian A; Beladan C; Iancu M; Călin A; Popescu BA; Jurcuţ R
Rom J Intern Med; 2009; 47(4):319-29. PubMed ID: 21179913
[TBL] [Abstract][Full Text] [Related]
15. C-reactive protein is increased in patients with degenerative aortic valvular stenosis.
Galante A; Pietroiusti A; Vellini M; Piccolo P; Possati G; De Bonis M; Grillo RL; Fontana C; Favalli C
J Am Coll Cardiol; 2001 Oct; 38(4):1078-82. PubMed ID: 11583885
[TBL] [Abstract][Full Text] [Related]
16. Effect of rosuvastatin on C-reactive protein and progression of aortic stenosis.
Chan KL; Dumesnil JG; Tam J; Ni A; Teo K
Am Heart J; 2011 Jun; 161(6):1133-9. PubMed ID: 21641360
[TBL] [Abstract][Full Text] [Related]
17. Relation of circulating C-reactive protein to progression of aortic valve stenosis.
Sánchez PL; Santos JL; Kaski JC; Cruz I; Arribas A; Villacorta E; Cascon M; Palacios IF; Martin-Luengo C;
Am J Cardiol; 2006 Jan; 97(1):90-3. PubMed ID: 16377290
[TBL] [Abstract][Full Text] [Related]
18. [Factors facilitating development of degenerative aortic valvular stenosis].
Andropova OV; Polubentseva EI; Anokhin VN
Klin Med (Mosk); 2005; 83(6):51-4. PubMed ID: 16075646
[TBL] [Abstract][Full Text] [Related]
19. Relations of inflammation and novel risk factors to valvular calcification.
Fox CS; Guo CY; Larson MG; Vasan RS; Parise H; O'Donnell CJ; D'Agostino RB; Keaney JF; Benjamin EJ
Am J Cardiol; 2006 May; 97(10):1502-5. PubMed ID: 16679093
[TBL] [Abstract][Full Text] [Related]
20. [Can we prevent the progression of aortic valve sclerosis and stenosis? The need for a prospective, randomized trial].
Scardi S; Cherubini A
Ital Heart J Suppl; 2005 Jul; 6(7):403-12. PubMed ID: 16082823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
